Investors / Germany / Beiersdorf Venture Capital
Beiersdorf Venture Capital
Corporate VC · Hamburg, Germany · Europe
Beiersdorf Venture Capital is the corporate venture arm of the skin care company Beiersdorf. It invests in and partners with startups, offering collaboration with Beiersdorf's R&D teams and access to its global brand platforms.
Invests inHealthcare & BiotechIndustrial & Manufacturing
In its own wordsskin carelife sciencesbiotechartificial intelligencesustainabilitydigital health
Your fit with Beiersdorf Venture Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBeiersdorf Venture Capital lists 13 checked portfolio companies on its own site and is named in 4 funding rounds. Its most frequent entry is Seed, 33% of the companies with a known first round. Its largest themes are Healthcare & Biotech (71%), Industrial & Manufacturing (21%) and Food & Agriculture (7%). 30% of its companies are based in United States. It invests most often alongside B Capital, Crane Venture Partners and Accel.
Counts come from funding rounds that name Beiersdorf Venture Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Beiersdorf Venture Capital's whole history. Rounds on record name 4 companies; its own site lists 13. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 33% |
| Series A | 33% |
| Series B | 33% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 33th | 13 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 64th | 33% of entries at pre-seed or seed |
| Evidence | 97th | 31% of companies confirmed by a round |
| Sector focus | 92th | 71% in its largest sector |
| Reach | 91th | 8 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| B Capital | 2 |
| Crane Venture Partners | 2 |
| Accel | 1 |
| Angel Invest | 1 |
| Atlantic | 1 |
| Avego | 1 |
| B Heroes | 1 |
| Bayer G4A | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers13100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 71% | 15% |
| Industrial & Manufacturing | 21% | 7% |
| Food & Agriculture | 7% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare Beiersdorf Venture Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Beiersdorf Venture Capital| Date | Company | Stage |
|---|---|---|
| 24 Feb 2026 | Series B | |
| 1 Dec 2025 | Series A | |
| 9 Sept 2025 | Round | |
| 29 Apr 2025 | Seed |
Round details for Beiersdorf Venture Capital
Amounts, full round histories and every co-investor in Beiersdorf Venture Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
13 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| cellvie develops medicines from cells, specifically using mitochondria for therapeutic purposes, including treating genetic diseases and ischemia-reperfusion injury | Healthcare & Biotech | Sept 2025Round | Page + round | |
| Deeplife develops digital twins of cells for drug discovery using multi-omics data, AI, and systems engineering. | Healthcare & Biotech | Portfolio page | ||
| DePoly recycles unsorted, dirty PET waste into virgin-grade raw materials | Industrial & Manufacturing | Apr 2025Seed | Page + round | |
| Dermanostic provides online dermatological consultations and treatments through an app | Healthcare & Biotech | Portfolio page | ||
| Evommune discovers and develops innovative therapies that target key drivers of chronic inflammatory disease. | Healthcare & Biotech | Portfolio page | ||
| Macro Biologics designs, patents, and produces advanced biomaterials for safer healthcare, clean food and water, and better packaging | Healthcare & Biotech | Portfolio page | ||
| Melt&Marble designs and produces next generation fats and lipids using precision fermentation for use in food and personal care products. | Food & AgricultureHealthcare & Biotech | Dec 2025Series A | Page + round | |
| ReVentas recycles plastics using a novel dissolution recycling technology to produce virgin-like polymer | Industrial & Manufacturing | Portfolio page | ||
| Rubedo discovers and develops medicines to keep people biologically young by targeting the pathologic cells that drive aging and diseases | Healthcare & Biotech | Portfolio page | ||
| Salvalco manufactures innovative eco aerosol valves | Industrial & Manufacturing | Portfolio page | ||
| S-Biomedic pioneers microbiome-based skincare for all by harnessing the full potential of the skin microbiome | Healthcare & Biotech | Portfolio page | ||
| Turbine provides a virtual lab platform for biopharma discovery, allowing users to run virtual experiments and validate hypotheses | Healthcare & Biotech | Feb 2026Series B | Page + round | |
| Vincere makes new medicines to treat age-related diseases including Parkinson’s and Kidney disease. | Healthcare & Biotech | Portfolio page |
About this data
site last read 7 Nov 2026- Site
- beiersdorf.com
- Last read
- 7 Nov 2026
- Watching since
- 7 Nov 2026
- Rounds since
- 29 Apr 2025
- Companies checked
- 13
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Beiersdorf Venture Capital's profile as data
Pull Beiersdorf Venture Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/beiersdorf.com
# also
GET /v1/firms/beiersdorf.com/portfolio
GET /v1/firms/beiersdorf.com/coinvestors
GET /v1/firms/beiersdorf.com/news